ScarX Therapeutics Overview
- Founded
-
2012
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
ScarX Therapeutics General Information
Description
Developer of innovative therapeutics intended to address excessive dermal scarring. The company's therapeutics are used to produce a small molecule therapeutic drug with anti-fibrotic activity that reduce dermal scarring during wound healing and also development of a novel therapeutic products, enabling patients to have better post-surgical outcomes following cosmetic and reconstructive plastic surgeries.
Contact Information
Website
www.scarxtherapeutics.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Personal Products
Primary Office
- 661 University Avenue
- Suite 465
- Toronto, Ontario M5G 1M1
- Canada
ScarX Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 11-Dec-2019 | 00.00 | Completed | Out of Business | ||
| 3. Early Stage VC (Series A) | 16-Feb-2016 | 000 | 00.00 | Completed | Clinical Trials - Phase 1 | |
| 2. Grant | 24-Jan-2013 | $1M | $1.7M | Completed | Pre-Clinical Trials | |
| 1. Early Stage VC | 25-Sep-2012 | $1.7M | $1.7M | Completed | Pre-Clinical Trials |
ScarX Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
